Policy Shift Sparks Packaging Overhaul 

Packaging Digest recently featured insights from Project Farma CEO, Anshul Mangal, in its latest coverage of the Trump administration’s new TrumpRx program and its potential ripple effects across the pharmaceutical industry. 

The initiative, which aims to reduce drug costs and reshore US manufacturing, could prompt significant changes in how pharmaceutical companies package, label, and distribute their products. As manufacturers like Pfizer prepare for more direct-to-consumer fulfillment models, the article explores how this policy shift may reshape everything from pack sizes to supply chain logistics.  

Click here to read the full article, Trump Drug Deal to Spur Packaging Changes, Pfizer First in Packaging Digest.